Metabolic decompensation in methylmalonic aciduria: Which biochemical parameters are discriminative?

Journal of Inherited Metabolic Disease

Volumn 35, Issue 5, 2012, Pages 797-806

  Zwickler, Tamaris ^a   Haege, Gisela ^a   Riderer, Alina ^a   Hörster, Friederike ^a   Hoffmann, Georg F ^a   Burgard, Peter ^a   Kölker, Stefan ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMMONIA; BICARBONATE; CARBOXYLIC ACID; CARNITINE;

ACID BASE BALANCE; ADULT; ALKALOSIS; ANAMNESIS; APPETITE DISORDER; ARTICLE; CARBON DIOXIDE TENSION; CHILD; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; DISEASE SEVERITY; EMERGENCY TREATMENT; FEMALE; FOLLOW UP; HUMAN; INFANT; INFECTION; MALE; MEDICAL DECISION MAKING; METABOLIC ACIDOSIS; METABOLIC DECOMPENSATION; METABOLIC DISORDER; METHYLMALONIC ACIDURIA; PH; PRESCHOOL CHILD; SYMPTOM; VOMITING;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADOLESCENT; ADULT; AMINO ACID METABOLISM, INBORN ERRORS; AMMONIA; BICARBONATES; CARNITINE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; YOUNG ADULT;

EID: 84866730043     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9426-1     Document Type: Article

References (24)

1. Abdi H (2007) Bonferroni and Sidak corrections for multiple comparisons. In: Salkind NJ (ed) Encyclopedia of Measurement and Statistics. Sage, Thousand Oaks, pp 103-107
2. Baumgartner ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inher Metab Dis 18:138-142
3. Coude FX, Sweetman L, Nyhan WL (1979) Inhibition by propionylcoenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest 64:1544-1551
4. Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104-112
5. Edgington ES (1995) Randomization tests, 3rd edn. Marcel-Dekker, New York, pp 1-409
6. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-452
7. Fenton WA, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2165-2193
8. Hörster F, Garbade SF, Zwickler T et al. (2009) Prediction of outcome in isolated methylmalonic acidurias: Combined use of clinical and biochemical parameters. J Inherit Metab Dis 32:630-639
9. Howell DC (2001) Resampling Procedures Version 1.3. Retrieved from http://www.uvm.edu/?dhowell/StatPages/Resampling/Resampling Package.zip on November 9, 2010
10. Leonard JV, Vijayaraghavan S, Walter JH (2003) The impact of screening for propionic and methylmalonic acidaemia. Eur J Pediatr 162:S21-S24
11. Marquard J, El Scheich T, Klee D, Schmitt M, Meissner T, Mayatepek E, Oh J (2011) Chronic pancreatitis in branched-chain organic acidurias - a case of methylmalonic aciduria and an overview of the literature. Eur J Pediatr 170:241-245
12. Morath MA, Okun JG, Müller IB, Sauer SW, Hörster F, Hoffmann GF, Kölker S (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria-A pathophysiological approach. J Inherit Metab Dis 31:35-43
13. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S246
14. Ogier de Baulny H, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM (2005) Methylmalonic and propionic acidaemias: Management and outcome. J Inherit Metab Dis 28:415-423
15. Okun JG, Hörster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674-14680
16. Saudubray JM, Nassogne MC, de Lonlay P, Touati G (2002) Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol 7:3-15
17. Sauer SW, Okun JG, Hoffmann GF, Kölker S, Morath MA (2008) Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism. Biochim Biophys Acta 1777:1276-1282
18. Schwab MA, Sauer SW, Okun JG et al. (2006) Secondary mitochondrial dysfunction in propionic aciduria, a pathogenic role for endogenous mitochondrial toxins. Biochem J 398(1):107-112
19. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
20. Smucker MD, Allan J., Carterette B (2007) A comparison of statistical significance tests for information retrieval evaluation. Proceedings of the sixteenth ACM conference on Conference on Information and Knowledge Management (CIKM). November 05-10, 2007, Lisbon, Portugal. ACM, New York, pp 623-632
21. Thompson GN, Chalmers RA, Walter JH et al. (1990) The use of metronidazole in the management of methylmalonic and propionic acidemias. Eur J Pediatr 149:792-796
22. Walter JH (2003) L-Carnitine in inborn errors of metabolism: What is the evidence? J Inherit Metab Dis 26:181-188
23. Walter JH, MacDonald A (2006) The use of amino acid supplements in inherited metabolic disease. J Inherit Metab Dis 29:279-280
24. Willard HF, Rosenberg LE (1980) Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts. Evidence for allelic heterogeneity, genetic compounds, and codominant expression. J Clin Invest 65:690-698